British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 37770126.
- Also identified by DOI 10.1136/gutjnl-2023-330029 and PMC identifier 10715509.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts from various specialties involved in the management of CCA, as well as patient/public representatives from AMMF (the Cholangiocarcinoma Charity) and PSC Support. Quality of evidence is presented using the Appraisal of Guidelines for Research and Evaluation (AGREE II) format. The recommendations arising are to be used as guidance rather than as a strict protocol-based reference, as the management of patients with CCA is often complex and always requires individual patient-centred considerations.
Medical subject headings
- Gastroenterology
- Cholangiocarcinoma
- Bile Duct Neoplasms